Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 6.46
+0.14 (2.22%)
Mar 9, 2026, 1:50 PM CET
Hyloris Pharmaceuticals Revenue
Hyloris Pharmaceuticals had revenue of 3.34M EUR in the half year ending June 30, 2025, with 74.54% growth. This brings the company's revenue in the last twelve months to 8.46M, up 30.42% year-over-year. In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M with 159.64% growth.
Revenue (ttm)
8.46M
Revenue Growth
+30.42%
P/S Ratio
20.92
Revenue / Employee
169.18K
Employees
50
Market Cap
176.96M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Onward Medical | 2.72M |
| European Medical Solutions | 49.47M |
| Celyad Oncology | 186.00K |
| Financière de Tubize | 13.26K |
| BioSenic | -2.39M |
| argenx SE | 3.62B |
| UCB SA | 7.74B |
| Oxurion NV | 2.00K |